| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Laboratory of Cell Biology and Immunology, Queen’s Center for Biomedical Research, Queen’s Medical Center, Honolulu, HI 96813; and
Department of Cell and Molecular Biology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96822
Cannabinoid modulation of immune responses is a pathological consequence of marijuana abuse and a potential outcome of therapeutic application of the drug. Moreover, endogenous cannabinoids are physiological immune regulators. In the present report, we describe alterations in gene transcription that occur after cannabinoid exposure in a mast cell line, RBL2H3. Cannabinoid exposure causes marked changes in the transcript levels for numerous genes, acting both independently of and in concert with immunoreceptor stimulation via Fc
RI. In two mast cell lines, we observed mRNA and protein expression corresponding to both CB1 and CB2 cannabinoid receptor isoforms, contrary to the prevailing view that CB1 is restricted to the CNS. We show that coexpression of the two isoforms is not functionally redundant in mast cells. Analysis of signaling pathways downstream of cannabinoid application reveals that activation of extracellular signal-regulated kinase, AKT, and a selected subset of AKT targets is accomplished by CB2 ligands and nonselective CB1/CB2 agonists in mast cells. CB1 inhibition does not affect AKT or extracellular signal-regulated kinase activation by cannabinoids, indicating that CB2 is the predominant regulatory receptor for these kinases in this cell context. CB1 receptors are, however, functional in these mast cells, since they can contribute to suppression of secretory responses.
This article has been cited by other articles:
|
|
 |
|
  A. N. Akopian, N. B. Ruparel, A. Patwardhan, and K. M. Hargreaves Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation J. Neurosci., January 30, 2008; 28(5): 1064 - 1075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Giudice, L. Rinaldi, M. Passarotto, F. Facchinetti, A. D'Arrigo, A. Guiotto, M. D. Carbonare, L. Battistin, and A. Leon Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells J. Leukoc. Biol., June 1, 2007; 81(6): 1512 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Blazquez, A. Carracedo, L. Barrado, P. J. Real, J. L. Fernandez-Luna, G. Velasco, M. Malumbres, and M. Guzman Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J, December 1, 2006; 20(14): 2633 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kraft and H. G. Kress Indirect CB2 Receptor and Mediator-Dependent Stimulation of Human Whole-Blood Neutrophils by Exogenous and Endogenous Cannabinoids J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 641 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vannacci, L. Giannini, M. B. Passani, A. Di Felice, S. Pierpaoli, G. Zagli, O. Fantappie, R. Mazzanti, E. Masini, and P. F. Mannaioni The Endocannabinoid 2-Arachidonylglycerol Decreases the Immunological Activation of Guinea Pig Mast Cells: Involvement of Nitric Oxide and Eicosanoids J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Sundstrom, D. M. Little, F. Villinger, J. E. Ellis, and A. A. Ansari Signaling through Toll-Like Receptors Triggers HIV-1 Replication in Latently Infected Mast Cells J. Immunol., April 1, 2004; 172(7): 4391 - 4401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vannacci, L. Giannini, E. Masini, and P. F. Mannaioni Cannabinoid-Induced Activation of ERK and AKT in Mast Cells May Be Mediated by Intracellular NO Production J. Immunol., September 15, 2003; 171(6): 2767 - 2767. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
